Intra-Articular Injection of Tenoxicam in the Treatment of Osteoarthritis of the Knee

REFERENCES

• Kramer J. S., Yelin E. H., Epstein W. V. Social and economic impacts of four musculoskeletal conditions. Arthritis Rheum 1983; 26: 901–907
   PubMed Web of Science ®Google Scholar
• Duckworth T. Lectures on Orthopaedics and Fractures. Blackwell Scientific Publicatons, Oxford 1980; 109–111
   Google Scholar
• Papathanassiou N. P. Intra-articular use of tenoxicam in degenerative osteoarthritis of the knee joint. J Intern Med Res 1994; 22: 332–337
   PubMed Web of Science ®Google Scholar
• Howell D. S. Pathogenesis of osteoarthritis. Am J Med 1986; 80: 24–28
   PubMed Web of Science ®Google Scholar
• Spector T. D., Hart D. J., Nandra D, Doyle D. V., Mackillop N, Gallimore J. R., Pepys M. B. Low-level increases in serum C-Reactive Protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997; 4: 723–727
   Google Scholar
• Adams M. E., Atkinson M. H., Lussier A. J., Schulz J. I., Siminovitch K. A., Wade J. P., Zummer M. The role of viscosupplementation with hylan G-F 20(Synvisc) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis and Cartilage 1995; 3: 213–226
   PubMed Web of Science ®Google Scholar
• Altman R. D., Hochberg M. C., Moskowitz R. W., Schnitzer T. J. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 1905; 43, 1915, 2000
   Google Scholar
• Todd P. A., Clissold S. P. Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases. Drugs 1991; 4: 625–646
   Google Scholar
• Cook T. M., Tuckey J. P., Nolan J. P. Analgesia after day-case knee arthroscopy: double-blind study of intra-articular tenoxicam, intra-articular bupivacaine and placebo. British Journal of Anaesthesia 1997; 78: 163–168
   PubMed Web of Science ®Google Scholar
• Croft P. Review of UK data on the rheumatic dis-eases-3: Osteoarthritis. Br J Rheumatol 1990; 29: 391–395
   PubMedGoogle Scholar
• Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke T. D., Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Long-ley S, Mankin H, McShane D. J., Medsger T, Meenan R, Mikkelsen W, Moskowitz R, Murphy W, Rothschild B, Segal M, Sokoloff L, Wolfe F. Development of criteria for the classification and reporting of osteoarthritis: Classification of Osteoarthritis of the Knee. Arthritis Rheum 1986; 29: 1039–1049
   PubMed Web of Science ®Google Scholar
• Altman R. D. The classification of osteoarthritis. J Rheumatol 1995; 22: 42–43
   Web of Science ®Google Scholar
• Rogind H, Nielsen B. B., Jensen B, Moller H. C. The effects of a physical training program on patients with osteoarthritis of the knees. Arch Phys Med Rehabil 1998; 79: 1421–1427
   PubMed Web of Science ®Google Scholar
• Jones A, Hopkinson N, Pattrick M, Berman P, Doherty M. Evaluation of a method for clinically assessing osteoarthritis of the knee. Ann Rheum Dis 1992; 51: 243–245
   PubMed Web of Science ®Google Scholar
• Bellamy N, Buchanan W. W., Goldsmith C. H., Campbell J, Stitt L. W. Validation study of WOMAC: A health status instrument for measuring clinically-important patient-relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip and knee. J Rheumatol 1988; 15: 1833–1840
   PubMed Web of Science ®Google Scholar
• Lequesne M. G. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 1997; 24: 779–781
   PubMed Web of Science ®Google Scholar
• Langdon C. G., Moran D. G., Jamieson V, Spence S, Hill S A. A multicentre study of tenoxicam for the treatment of osteoarthritis and rheumatoid arthritis in general practice. J Intern Med Res 1990; 18: 489–496
   PubMed Web of Science ®Google Scholar
• Ibrahima K, Kodjo G, Issa S, Seye L, Cisse F, Eassey G, Rietiker S. Clinical efficacy and tolerability of tenoxicam in African patients with osteoarthritis, rheumatoid arthritis, tendinitis and/or bursitis: an open study. Curr Med Res and Opin 1991; 12: 471–478
   PubMed Web of Science ®Google Scholar
• Fenner H. 250 Million patient-days with tenoxicam results and perspectives. Drug Invest 1990; 2: 1–6
   Google Scholar
• Winterer W. Comparative gastroduodenal tolerance and efficacy of tenoxicam and diclofenac SR in the treatment of osteoarthritic patients. European Journal of Clinical Research 1994; 5: 125–134
   Google Scholar
• Riedemann P. J., Bersinic S, Cuddy L. J., Torrance W, Tugwell P. X. A study to determine the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in patients with osteoarthritis: A meta-analysis. J Rheumatol 2095; 20, 2103, 1993
   Google Scholar
• Colbert S. T., Curran E, O'Hanlon D. M., Moran R, McCarroll M. Intra-articular tenoxicam improves postoperative analgesia in knee arthroscopy. Can J Anaesth 1999; 46: 653–657
   PubMed Web of Science ®Google Scholar
• Elhakim M, Fathy A, Elkott M, Said M. M. Intra-articular tenoxicam relieves post-arthroscopy pain. Acta Anaesthesiol Scand 1997; 41(1088)
   PubMedGoogle Scholar
• Elhakim M, Nafie M, Hassin M. Combination of intraarticular tenoxicam, lidocaine, pethidine for outpatient knee arthroscopy. Acta Anaesthesiol Scand 1999; 43: 803–808
   PubMed Web of Science ®Google Scholar
• Petrella R. J., DiSilvestro M. D., Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee. Arch Intern Med 2002; 162: 292–298
   PubMed Web of Science ®Google Scholar
• Fisher N. M., Gresham G, Pendergast D. R. Effects of a quantitative pogressive rehabilitation program applied unilaterally to the osteoarthritic knee. Arch Phys Med Rehabil 1993; 74: 1319–1326
   PubMed Web of Science ®Google Scholar
• Van Baar M. E., Assendelft W. J., Dekker J, Oosten-dorp R. A., Bijlsma J WJ. Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee. Arthritis Rheum 1999; 42: 1361–1369
   PubMed Web of Science ®Google Scholar
• Ettinger W. H., Burns R, Messier S. P., Applegate W, Rejeski W. J., Morgan T, Shumaker S, Berry M. J., O'Toole M, Monu J, Craven T. A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis: The fitness arthritis and seniors trial (FAST). JAMA 1997; 277: 25–31
   PubMed Web of Science ®Google Scholar
• Slemenda C, Brandt K. D., Heilman D. K., Mazzuca S, Braunstein E. M., Katz B. P., Wolinsky F. D. Quadriceps weakness and osteoarthritis of the knee. Ann Intern Med 1997; 127: 97–104
   PubMed Web of Science ®Google Scholar
• Fisher N. M., Pendergast D. R., Gresham G. E., Calkins E. Muscle rehabilitation: Its effect on muscular and functional performance of patients with knee osteoarthritis. Arch Phys Med Rehabil 1991; 72: 367–374
   PubMed Web of Science ®Google Scholar
• Gonzales J. P., Todd P. Tenoxicam: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1987; 34: 289–310
   PubMed Web of Science ®Google Scholar
• Bannwarth B, Netter P, Lapicque F, Mainard D, Fener P, Gillet P, Gaucher A. Tenoxicam concentrations in synovium and joint cartilage in humans. Agents and Actions 1991; 32: 295–298
   PubMedGoogle Scholar
• Vignon E, Mathieu P, Louisot P, Richard M. Vitro effect of nonsteroidal antiinflammatory drugs on proteoglycanase and collagenase activity in human osteoarthritic cartilage. Arthritis Rheum 1991; 34: 1332–1335
   PubMed Web of Science ®Google Scholar
• Manicourt D. H., Egeren A. D., Haazen L, Deux-chaisnes C. N. Effects of tenoxicam and aspirin on the metabolism of proteoglycans and hyaluronan in normal and osteoarthritic human articular cartilage. Br J Pharmacol 1994; 113: 113–120
   Web of Science ®Google Scholar
• La Montagna G, Tirri G, Cacace E, Perpignano G, Covelli M, Pipitone V, D'Agostino P, Magaro M, Ferraccioli G, Mascia M. T., Manzini E, Minari C, Barreca C, Marcolongo R, Paresce E, Colombo B. Quality of life assessment during six months of NSAID treatment: Gonarthrosis and Quality of Life (GOAL) study. Clin Exp Rheumatol 1998; 16: 49–54
   PubMed Web of Science ®Google Scholar
• Huskisson E. C., Berry H, Gishen I, Jubb R. W., Whitehead J. Effects of anti-inflammatory drugs on the progression of osteoarthritis of the knee. J Rheumatol 1941; 22, 1946, 1995
   Google Scholar
• Nilsen O. G. Clinical pharmacokinetics of tenoxicam. Clin Pharmacokinet 1994; 26: 16–43
   PubMed Web of Science ®Google Scholar
• Itzkowitch D, Ginsberg F, Leon M, Bernard V, Appelboom T. Peri-articular injection of tenoxicam for painful shoulders: a double-blind, placebo controlled trial. Clin Rheumatol 1996; 15: 604–609
   PubMed Web of Science ®Google Scholar